Cor pulmonale refers to the structural and functional changes in the right ventricle caused by diseases of the lungs, pulmonary circulation or respiratory process. The term thus expresses a causal relationship between the respiratory system, vascular load and the right heart. It is not synonymous with every form of right heart failure and does not identify a single disease: dysfunction due to right ventricular infarction, congenital heart disease or primary left heart disease requires a different clinical classification.
The concept remains useful because it highlights the cardiopulmonary unit. Diseased lungs compromise the heart not only by reducing oxygen availability but also by changing vascular resistance, vascular compliance, intrathoracic pressures and venous return. The right ventricle may adapt to these changes or lose its ability to maintain cardiac output. Edema is only one possible late manifestation: clinically significant right heart involvement may precede overt congestion or present with reduced exercise capacity and low cardiac output.
The rate at which afterload increases is a major determinant of the response. In acute cor pulmonale, the ventricle has insufficient time to develop structural adaptation and may dilate rapidly, as in pulmonary embolism or ARDS. Even a pressure that is not extremely high may already be incompatible with adequate cardiac output. Severity is therefore not defined by exceeding an echocardiographic pressure threshold but by the effect on function and perfusion.
In chronic cor pulmonale, overload develops over time and induces hypertrophy, changes in geometry and progressive contractile adaptation. COPD, interstitial lung diseases, hypoventilation and chronic vascular diseases are important settings. Adaptation may remain compensated for varying periods; when it becomes inadequate, dilatation, tricuspid regurgitation and congestion appear. A respiratory exacerbation or embolism may superimpose acute injury on a heart that has already undergone remodeling, creating an acute-on-chronic presentation.
Pulmonary hypertension describes an abnormality of pressure in the pulmonary circulation, whereas cor pulmonale describes its right heart consequences in a particular etiologic context. The terms are related but not interchangeable. One patient may have an early vascular phase without evident cardiac remodeling; another may maintain only moderately elevated pressure because the impaired ventricle can no longer generate high flow and pressure. An integrated assessment avoids interpreting falling pressure as certain improvement.
Vascular obstruction reduces the number of channels available for blood flow. In acute embolism, the effect is rapid and is accompanied by vasoconstriction; in CTEPH, organized obstructions and microvascular disease chronically increase the load. Proliferative arterial vascular disease can also cause substantial right heart dysfunction. Identifying the type of obstruction is crucial because anticoagulation, endarterectomy, angioplasty and medical therapies act on different components and are not interchangeable.
In chronic lung diseases, capillary destruction in emphysema, distortion caused by fibrosis and endothelial injury narrow and stiffen the vascular bed. Pulmonary hypertension associated with lung diseases therefore does not depend solely on oxygen saturation. Hyperinflation may reduce venous return and increase mechanical load, while exacerbations add acidosis and hypoxemia. In interstitial lung disease, reduced respiratory reserve makes even non-extreme increases in vascular load clinically relevant.
Alveolar hypoxia causes vasoconstriction and, when persistent, remodeling. The hypoxic component is particularly important in hypoventilation and certain environmental exposures. Oxygen may reduce the vasoconstrictor stimulus but does not replace ventilatory support if the problem is inadequate CO2 elimination. Positive pressure also has two opposing effects: it improves alveolar recruitment and arterial blood gases but may impair right heart filling if excessive for the lungs' needs.
The normal right ventricle is a pump suited to a low-impedance circuit. Its performance depends on preload, contractility, resistance and the pulsatile component of the load, as well as septal contribution. A gradual increase can be compensated for through hypertrophy and increased contractility; an abrupt increase is more likely to cause dilatation and inefficiency. Ventriculoarterial coupling describes the capacity to match function to the load and helps explain why patients with similar pressures can have very different clinical presentations.
With uncoupling, end-systolic volume increases and dilatation stretches the tricuspid annulus. Regurgitation further reduces the amount of blood reaching the lungs. Venous pressure rises, while septal displacement and pericardial constraint limit left ventricular filling. Congestion and low cardiac output can therefore coexist: a patient with edema does not necessarily have adequate perfusion, and giving fluids solely because arterial pressure is low may worsen the situation.
Organ congestion affects the liver, kidneys and gastrointestinal tract. It may cause ascites, abnormal liver function tests, worsening renal function, early satiety and reduced absorption of medications. However, edema in respiratory diseases does not always establish severe right ventricular systolic failure: hypercapnia and neurohormonal activation may contribute to sodium retention. Diagnosis requires concordance between clinical findings, cardiac function and the underlying disease, rather than using a single sign to define the syndrome.
Dyspnea and fatigability are common but overlap with symptoms of the underlying respiratory disease. A loss of independence not explained by pulmonary function, new syncope, chest pain or congestion increases suspicion of circulatory involvement. In acute forms, hypotension, cold skin, confusion and oliguria suggest possible low-output failure. In chronic forms, the medical history must cover smoking, exposures, exacerbations, oxygen use, sleep disorders and thromboembolic history, as well as concomitant heart disease.
Echocardiography assesses right ventricular size, geometry and function, tricuspid regurgitation, the septum and the left heart. TAPSE, annular systolic velocity and fractional area change provide complementary information but depend on loading conditions and must not be interpreted in isolation. The absence of a measurable tricuspid regurgitation jet does not exclude disease. Cardiac magnetic resonance imaging is useful when more accurate quantification of chamber volumes is needed or the echocardiographic window is inadequate; CT can simultaneously characterize the lungs, vessels and chamber size.
Etiologic investigations depend on the clinical setting. Arterial blood gas analysis, pulmonary function tests and sleep studies characterize gas exchange and ventilation; CT pulmonary angiography and perfusion scintigraphy answer different thromboembolic questions. ECG and biomarkers document overload or injury without independently identifying its cause. Right heart catheterization confirms and classifies hemodynamics when the result may change treatment. In shock, investigations must be organized so that urgent therapy is not delayed and patients are not exposed to transfers they cannot tolerate.
Treating the underlying cause is the cornerstone of management. Prompt removal of an obstruction may unload the ventricle in high-risk pulmonary embolism; controlling respiratory disease and ventilation reduces vasoconstrictor stimuli and cardiac work in chronic forms. PAH medications are appropriate for phenotypes with established indications, not simply because right ventricular dilatation is present. Treatment must therefore be linked to etiologic classification because the same cardiac finding can result from processes that respond to different therapies.
Management of circulating volume aims for adequate filling without excessive distension. In congested patients, diuretics may improve organ function and ventricular interdependence; in acute presentations with true preload depletion, cautious fluid administration followed by reassessment may be useful. Oxygen and ventilation are adjusted to the documented deficit. In shock, vasopressors, inotropes or extracorporeal support may be required, with perfusion targets and a defined strategy to treat the causative mechanism.
Continuity of care includes rehabilitation after stabilization, nutrition, adherence to medical devices and management of comorbidities. Anticoagulation, treatment of left heart failure and management of arrhythmias follow their own indications and are not inferred from the name of the syndrome. In patients with advanced disease, transplant referral should precede irreversible multiorgan dysfunction when eligibility criteria are met. Symptom management and care planning remain part of the pathway even when disease-modifying options are limited.
Prognosis depends on the speed of onset, reversibility of the cause and right ventricular reserve. In acute forms, early recognition and treatment may allow substantial recovery; in chronic forms, the course is linked to both vascular disease and progression of respiratory disease. Estimated pressure alone is insufficient: cardiac output, congestion, renal function, biomarkers and exercise capacity complete its interpretation. Changes must be assessed against the previous state and the conditions of support.
Follow-up assesses independence, exacerbations, signs of fluid retention, oxygenation and cardiac function. New dyspnea, syncope or edema should prompt a search for a precipitating factor and must not automatically be attributed to natural disease progression. Arrhythmias, infections, thromboembolism and interruption of treatment may destabilize a fragile equilibrium. Joint assessment of the heart and lungs helps determine when a patient needs a straightforward treatment adjustment and when the cause must be reassessed or an advanced strategy discussed.
Informational notice: the information contained on this page is provided solely for informational and educational purposes and does not replace the advice, diagnosis or treatment provided by a physician. If needed, always consult a qualified healthcare professional.
Artificial intelligence transparency: this page was created with the support of artificial intelligence tools, used to assist in the production and processing of its content.